Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors
- PMID: 12454484
- DOI: 10.1107/s090744490201569x
Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors
Abstract
In bacteria the biosynthesis of all nascent polypeptides begins with N-formylmethionine. The post-translational removal of the N-formyl group is carried out by peptide deformylase (PDF). Processing of the N-formyl group from critical bacterial proteins is required for cell survival. This formylation/deformylation cycle is unique to eubacteria and is not utilized in eucaryotic cytosolic protein biosynthesis. Thus, inhibition of PDF would halt bacterial growth, spare host cell-function, and would be a novel mechanism for a new class of antibiotic. Diffraction-quality Se-met crystals of S. aureus PDF were prepared that belong to space group C222(1) with unit cell parameters of a = 94.1 b = 121.9 c = 47.6 A. Multiple anomalous dispersion data were collected at the Advanced Photon Source 17-ID beamline and used to solve the PDF structure to 1.9 A resolution. Crystals were also prepared with three PDF inhibitors: thiorphan, actinonin and PNU-172550. The thiorphan and actinonin co-crystals belong to space group C222(1) with similar unit-cell dimensions. Repeated attempts to generate a complex structure of PDF with PNU-172550 from the orthorhombic space group were unsuccessful. Crystallization screening identified an alternate C2 crystal form with unit-cell dimensions of a = 93.4 b = 42.5 c = 104.1 A, beta = 93 degrees.
Similar articles
-
Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.Acta Crystallogr D Biol Crystallogr. 2004 Jan;60(Pt 1):137-9. doi: 10.1107/s0907444903022480. Epub 2003 Dec 18. Acta Crystallogr D Biol Crystallogr. 2004. PMID: 14684909
-
Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Jan 1;61(Pt 1):150-2. doi: 10.1107/S1744309104032440. Epub 2004 Dec 24. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005. PMID: 16508119 Free PMC article.
-
Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133.Biochemistry. 2000 Feb 1;39(4):779-90. doi: 10.1021/bi9919899. Biochemistry. 2000. PMID: 10651644
-
Novel approaches to antimicrobial therapy: peptide deformylase.Curr Opin Drug Discov Devel. 2002 Sep;5(5):785-92. Curr Opin Drug Discov Devel. 2002. PMID: 12630299 Review.
-
Peptide deformylase as an antibacterial target: a critical assessment.Curr Opin Pharmacol. 2006 Oct;6(5):445-52. doi: 10.1016/j.coph.2006.06.003. Epub 2006 Aug 9. Curr Opin Pharmacol. 2006. PMID: 16904375 Review.
Cited by
-
Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.Biochemistry. 2009 Aug 18;48(32):7595-607. doi: 10.1021/bi900600b. Biochemistry. 2009. PMID: 19627112 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous